News | January 27, 2009

AF Summit Returns to Heart Rhythm 2009

January 28, 2009 - The AF Summit returns this year during Heart Rhythm 2009, set for May 13-16 in Boston, after a sold-out event at Heart Rhythm 2007.

This one-and-a-half-day summit will highlight the latest advances in atrial fibrillation and including a jointly sponsored session with the American Association for Thoracic Surgery (AATS).

The sessions on Wednesday, May 13 will cover pushing the envelope of scientific and personal discovery, ablative intervention in 2010, ablation vs. surgery for AF and a keynote by Dr. J. Craig Venter.

On Thursday, May 14 the course will cover critical issues in AF therapy and outcome based report cards

In addition to the AF Summit, there are also hundreds of other informative, educational sessions with world-renowned faculty members.

Register early to ensure your seat at ticketed functions and secure a hotel reservation.

For more information: www.hrsonline.org


Related Content

News

Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...

Home September 08, 2026
Home
News

Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...

Home September 02, 2026
Home
News

July 8, 2026 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy ...

Home July 08, 2026
Home
News

May 21, 2026 — Adagio Medical Holdings, a provider of catheter ablation technologies for treating cardiac arrhythmias ...

Home May 22, 2026
Home
News

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...

Home April 29, 2026
Home
News

April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...

Home April 27, 2026
Home
News

April 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation ...

Home April 27, 2026
Home
News

April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...

Home April 13, 2026
Home
News

In a milestone for Broward Health in Ft. Lauderdale, Fla., Jose L. Baez-Escudero, M.D., chief of cardiology and ...

Home March 24, 2026
Home
News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
Subscribe Now